video thumbnail

AKT PI3K mTOR Pathway (Inflammation Part 8)

Duration: 37:01

Write A New Comment

1 Comments

...

theshackletons@*.com

Sep 18 2024, 2:17 am

This was very good ,it tied everything together. Many thanks.

...

aliza@*.com

Sep 19 2024, 12:39 pm

Thank you.

Phosphatidylinositol-3-kinase (PI3K/AKT/mammalian target of rapamycin [mTOR]) is one of the most important intracellular pathways. It can be considered as the regulator of cancer. Dysregulation of this pathway is often implicated in chronic inflammatory diseases and is a key driver in the development and progression of various cancers. By exploring how this pathway can be modulated, we can gain insights into potential therapeutic strategies for managing these conditions.

Objectives:
What is AKT/PI3K Pathway?
What are the results of AKT/PI3K pathway activation?
What drugs and supplements can modulate this pathway?

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
 

PI3K signalling in inflammation - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S1388198114002583

AKT/PI3K Signaling Pathway | Rockland
https://www.rockland.com/resources/akt-pi3k-signaling-pathway/

PI3K/Akt/mTOR signaling pathway. PI3K signaling starts by the... | Download Scientific Diagram
https://www.researchgate.net/figure/PI3K-Akt-mTOR-signaling-pathway-PI3K-signaling-starts-by-the-activation-of-either-a_fig2_349706150

Targeting PI3K in cancer: mechanisms and advances in clinical trials | Molecular Cancer | Full Text
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-019-0954-x

The PI3K/AKT pathway in obesity and type 2 diabetes - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158718/

 

  • What is AKT/PI3K Pathway?
  • What are the results of AKT/PI3K pathway activation?
  • What drugs and supplements can modulate this pathway?
     

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Chronic Inflammation

Related Videos